Preferred Stock and Warrants: (Details Textual) - USD ($) |
12 Months Ended | |
|---|---|---|
Nov. 13, 2015 |
Dec. 31, 2015 |
|
| Minimum Daily Volume Requirement Amount | $ 150,000 | |
| Stock Issued During Period, Value, New Issues | $ 0 | |
| Katalyst Securities LLC [Member] | ||
| Private placement Agent Fee Percentage | 1.00% | |
| Warrants issued to placement agent description | each closing, the Company will deliver to Katalyst warrants exercisable for a period of five years from the date of the Initial Closing to purchase a number of shares of the Company’s common stock equal to 10% of the number of Units purchased by any Placement Agent Investors who are not Institutional Placement Agent Investors (“Placement Agent Retail Investors”) with exercise prices as apportioned as follows: (x) 25% of such number of warrants shall be exercisable for common stock at an exercise price of $0.01 per share (“Penny Broker Warrant”) and (y) 75% of such number of warrants shall be exercisable for common stock at an exercise price of $0.60 per share (the “IV Broker Warrant” and collectively with the Institutional Broker Warrant and the Penny Broker Warrant, the “Broker Warrants”). | |
| Minimum [Member] | Katalyst Securities LLC [Member] | ||
| Proceeds from Issuance of Private Placement | $ 5,000,000 | |
| Securities Purchase Agreement [Member] | ||
| Resale Percentage of Series B Stock | 150.00% | |
| Private placement Agent Fee Percentage | 10.00% | |
| Over-Allotment Option [Member] | Securities Purchase Agreement [Member] | ||
| Proceeds from Issuance of Private Placement | $ 5,000,000 | |
| Sale of Stock, Number of Shares Issued in Transaction | 25,716,534 | |
| Sale of Stock, Price Per Share | $ 0.60 | |
| Over-Allotment Option [Member] | Securities Purchase Agreement [Member] | Minimum [Member] | ||
| Sale of Stock, Consideration Received on Transaction | $ 5,000,000 | |
| Over-Allotment Option [Member] | Securities Purchase Agreement [Member] | Maximum [Member] | ||
| Sale of Stock, Consideration Received on Transaction | $ 15,000,000 | |
| Private Placement Initial Closing [Member] | Securities Purchase Agreement [Member] | ||
| Sale of Stock, Description of Transaction | (a) an institutional investor that focuses on the biotech industry, (b) an investor of the Company’s Series A Stock, (c) any investor investing under $5,000 or (d) any person approved in writing by each of those Buyers who are institutional investors and such Buyer’s purchase price (together with such Buyer’s institutional affiliates) equals or exceeds $1,000,000 (the “Large Buyers”). | |
| Proceeds from Issuance of Common Stock | $ 15,330,000 | |
| Private Placement [Member] | ||
| Sale of Stock, Description of Transaction | (i) one one-hundredth share of Series B Stock, convertible into one share of the Company’s common stock (“Common Stock”), (ii) one warrant to acquire, at an exercise price of $0.80 per share with an expiration date five years from the date of issuance, one share of Common Stock (the “Series A Warrant”), (iii) one warrant to acquire, at an exercise price of $0.80 per share with an expiration date of one year life from the date of issuance, one share of Common Stock (the “Series B Warrant”), (iv) one warrant to acquire, at an exercise price of $1.25 per share with an expiration date of five years from the issuance date, one share of Common Stock (the “Series C Warrant”), (v) one warrant, which is contingent upon the exercise of the Series B Warrant, to acquire, at an exercise price of $1.00 per share with an expiration date that is five years from the date of the initial exercise of the Series B Warrant, one share of Common Stock (the “Series D Warrant”), and (vi) one warrant, which is contingent upon the exercise of the Series C Warrant, to acquire, at an initial exercise price of $1.50 per share with an expiration date that is five years from the date of the initial exercise of the Series C Warrant, one share of Common Stock (the “Series E Warrant”, and together with the Series A Warrant, the Series B Warrant, the Series C Warrant and the Series D Warrant, the “Investor Warrants”). | |
| Series B Convertible Redeemable Preferred Stock [Member] | ||
| Preferred Stock, Shares Authorized | 333,333 | |
| Preferred Stock, Par or Stated Value Per Share | $ 0.0001 | |
| Dividends Payable, Amount Per Share | $ 0.08 | |
| Stock Issued During Period, Shares, New Issues | 518,406 | |
| Stock Issued During Period, Value, New Issues | $ 311,000 |